Head-to-head · Cost-Efficiency Index
FuturHealth vs Meto
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
FuturHealth
Cost-first shoppers who want want a bundled coaching-plus-medication membership rather than a bare-bones prescription-only service.
Visit FuturHealthMeto
Cost-first shoppers who want peptide/longevity enthusiasts who want lab-verified dosing across multiple protocols, not GLP-1-first shoppers.
Visit MetoThe verdict
FuturHealth and Meto tie on the Cost-Efficiency Index at 44/100, so neither wins outright on the numbers. For most shoppers we'd start with FuturHealth (ranked #474, a hair above #480) — Cost-first shoppers who want want a bundled coaching-plus-medication membership rather than a bare-bones prescription-only service. But Meto is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs FuturHealth.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | FuturHealth | Meto |
|---|---|---|
| Cost-Efficiency Index | 44/100 | 44/100 |
| Semaglutide / mo | Not disclosed | $199/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide / mo | Not disclosed | $199/mo (starting dose, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | — | $2,388 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #474 | #480 |
FuturHealth
44/100Where the value is
- Advertised starting price of $99/month is one of the lowest headline figures in the category
- Bundles clinician guidance and a personalized nutrition plan into the membership rather than selling medication alone
- Weight-loss guarantee: refunds the initial program fee if you follow the program and see no weight loss
The tradeoffs
- The $99/month figure's scope is undisclosed — the site never states whether it includes the medication itself or is a platform fee with medication billed on top
- No dosing tiers or per-medication (semaglutide vs. tirzepatide vs. brand-name) pricing is published anywhere on the public site
Meto
44/100Where the value is
- Requires actual bloodwork/metabolic panel before prescribing, a stronger clinical gate than many peers
- Transparent line-item pricing across a wide menu of protocols
- Combined GLP-1 pricing is comparatively affordable relative to single-drug peers
The tradeoffs
- GLP-1 is a minor line item on a broader peptide platform, not the core focus
- Semaglutide and tirzepatide are not priced or dosed separately -- shoppers can't compare against single-drug competitors cleanly
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.